FARINA, LUCIA
 Distribuzione geografica
Continente #
EU - Europa 2.414
NA - Nord America 1.656
AS - Asia 1.050
SA - Sud America 62
AF - Africa 5
Continente sconosciuto - Info sul continente non disponibili 3
OC - Oceania 3
Totale 5.193
Nazione #
US - Stati Uniti d'America 1.644
GB - Regno Unito 888
DE - Germania 500
CN - Cina 441
SE - Svezia 278
SG - Singapore 251
IT - Italia 225
RU - Federazione Russa 175
IN - India 118
UA - Ucraina 98
TR - Turchia 81
IE - Irlanda 68
KR - Corea 68
FI - Finlandia 43
EU - Europa 42
NL - Olanda 41
FR - Francia 37
CO - Colombia 29
BR - Brasile 27
VN - Vietnam 26
HK - Hong Kong 17
ID - Indonesia 17
JP - Giappone 16
BE - Belgio 15
PL - Polonia 12
DK - Danimarca 11
CA - Canada 10
RO - Romania 5
AT - Austria 3
CL - Cile 3
CZ - Repubblica Ceca 3
UZ - Uzbekistan 3
AR - Argentina 2
CH - Svizzera 2
ES - Italia 2
HU - Ungheria 2
IL - Israele 2
IQ - Iraq 2
MX - Messico 2
NZ - Nuova Zelanda 2
SC - Seychelles 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AU - Australia 1
BD - Bangladesh 1
BO - Bolivia 1
CY - Cipro 1
EE - Estonia 1
EG - Egitto 1
GE - Georgia 1
HR - Croazia 1
LV - Lettonia 1
MA - Marocco 1
MD - Moldavia 1
MY - Malesia 1
PH - Filippine 1
PT - Portogallo 1
SA - Arabia Saudita 1
SK - Slovacchia (Repubblica Slovacca) 1
SY - Repubblica araba siriana 1
TH - Thailandia 1
TN - Tunisia 1
Totale 5.233
Città #
Southend 808
Frankfurt am Main 326
Chandler 188
Singapore 180
Seattle 127
Beijing 114
Ashburn 98
Ann Arbor 91
Milan 91
Wilmington 88
Princeton 87
Jacksonville 80
Fairfield 72
Dublin 67
Council Bluffs 56
Woodbridge 55
Redmond 50
Somerville 50
Houston 46
Nanjing 44
Dearborn 43
Des Moines 36
Bengaluru 35
Andover 31
Sakarya 30
Bogotá 29
Sunnyvale 29
Mountain View 28
Serra 27
Boardman 26
Berlin 21
Santa Clara 20
Cambridge 19
Jinan 19
New York 19
Shanghai 19
Nanchang 17
Dong Ket 16
Shenyang 16
Brussels 15
Hebei 13
Warsaw 12
Changsha 11
Hong Kong 11
Guangzhou 10
Hangzhou 10
Los Angeles 10
Phoenix 10
Fuzhou 9
Verona 9
Bitonto 8
Hanover 8
Jiaxing 8
Kunming 8
Toronto 8
Auburn Hills 7
Eitensheim 7
Haikou 7
Hefei 7
Jakarta 7
Zhengzhou 7
Hamburg 6
Helsinki 6
Mumbai 6
Seoul 6
Taiyuan 6
Tianjin 6
Falkenstein 5
Falls Church 5
Noginsk 5
Redwood City 5
Roxbury 5
San Diego 5
Washington 5
Rome 4
San Jose 4
Suzhou 4
Wuhan 4
Xiamen 4
Amsterdam 3
Brasília 3
Brno 3
Bühl 3
Central District 3
Fremont 3
Kent 3
Kurita 3
Ningbo 3
North Bergen 3
Nuremberg 3
São Paulo 3
Tokyo 3
Budapest 2
Chicago 2
Chongqing 2
Cupertino 2
Duncan 2
Grafing 2
Göteborg 2
Hounslow 2
Totale 3.546
Nome #
High-dose chemotherapy followed by autologous transplantation may overcome the poor prognosis of diffuse large B-cell lymphoma patients with MYC/BCL2 co-expression 323
Haploidentical stem cell transplantation after a reduced-intensity conditioning regimen for the treatment of advanced hematologic malignancies : posttransplantation CD8-depleted donor lymphocyte infusions contribute to improve T-cell recovery 220
Qualitative and quantitative polymerase chain reaction monitoring of minimal residual disease in relapsed chronic lymphocytic leukemia : early assessment can predict long-term outcome after reduced intensity allogeneic transplantation 202
The Role of Autologous and Allogeneic Stem Cell Transplantation in Follicular Lymphoma in The New Drugs Era 187
Lamivudine prophylaxis prevents hepatitis B virus reactivation in anti-HBc positive patients under rituximab for non-Hodgkin lymphoma 172
Haemato-oncology and burnout : an Italian survey 169
Allogeneic stem cell transplantation following reduced-intensity conditioning can induce durable clinical and molecular remissions in relapsed lymphomas : pre-transplant disease status and histotype heavily influence outcome 162
CD52 antigen expressed by malignant plasma cells can be targeted by alemtuzumab in vivo in NOD/SCID mice 157
Long-term outcome of ric-allo SCT for myeloma 156
Dose-Adjusted Epoch and Rituximab for the treatment of double expressor and double hit diffuse large B-cell lymphoma: impact of TP53 mutations on clinical outcome 152
Antibiotic prophylaxis before dental procedures may reduce the incidence of osteonecrosis of the jaw in patients with multiple myeloma treated with bisphosphonates 142
Reduced-intensity conditioning containing low-dose alemtuzumab before allogeneic peripheral blood stem cell transplantation: graft-versus-host disease is decreased but T-cell reconstitution is delayed 138
Current role of allogeneic stem cell transplantation in follicular lymphoma 137
The hematopoietic cell transplantation comorbidity index (HCT-CI) predicts clinical outcomes in lymphoma and myeloma patients after reduced-intensity or non-myeloablative allogeneic stem cell transplantation 137
Allogeneic stem cell transplantation after a RIC regimen prolongs the survival in patients with Hodgkin’s Lymphoma relapsed after high dose chemotherapy : a retrospective study based on donor availability 137
Allogeneic Stem Cell Transplantation for Relapsed/Refractory B-Cell Lymphomas: Results of a Multicenter Phase II Prospective Trial Including Rituximab in the Reduced Intensity Conditioning Regimen 132
The hematopoietic cell transplantation-specific comorbidity index (HCT-CI) predicts survival and non-relapse mortality in lymphoma and myeloma patients receiving a RIC allograft 130
Pre-emptive CD8-depleted donor lymphocyte infusions to overcome long-lasting immune deficiency after haploidentical stem cell transplantation with a reduced-intensity conditioning regimen 130
Efficacy and safety of cytarabine-based regimens for mobilization of peripheral blood stem cells in multiple myeloma 129
Reduced intensity allogeneic stem cell transplantation is an effective salvage treatment for relapsed non-Hodgkin’s and Hodgkin’s lymphomas 126
Peripheral blood CD34+ cell monitoring after cyclophosphamide and granulocyte-colony-stimulating factor : an algorithm for the pre-emptive use of plerixafor 123
Improved Immune Reconstitution Following Pre-Emptive CD8-Depleted Donor Lymphocyte Infusions (DLIs) after Haploidentical Stem Cell Transplantation (SCT) Using a Reduced-Intensity Conditioning (RIC) Regimen 122
Antibiotic prophylaxis before dental procedures can reduce ONJ incidence 121
CD8-depleted donor lymphocyte infusions can boost immune reconstitution after haploidentical stem cell transplantation following reduced-intensity conditioning regimen 120
Molecular remission after reduced intensity allogeneic transplantation in chronic lymphocytic leukemia : a surrogate marker of the GVL effect that predicts survival and overcomes poor prognostic factor 116
Reduced-intensity allogeneic stem cell transplantation using related haploidentical donors for relapsed or refractory lymphomas : evidence of anti-tumour activity in poor prognosis disease 110
Allogeneic transplantation for Hodgkin's lymphoma 109
CD8-depleted donor lymphocyte infusions can improve both T- and B-cell reconstitution after allogeneic stem cell transplantation from haploidentical family donors 108
Pre-emptive CD8-depleted donor lymphocyte infusions to overcome long-lasting immune deficiency after haploidentical stem cell transplantation with a reduced intensity conditioning regimen 106
The hematopoietic cell transplantation-specific comorbidity index (HCT-CI) predicts survival and non-relapse mortality in lymphoma and myeloma patients receiving a RIC allograft 106
Qualitative and Quantitative PCR Monitoring of MRD : Practical Implications of a Surrogate Marker for GVL Effect after RIC Allogeneic Transplantation in Relapsed Chronic Lymphocytic Leukemia 105
The hematopoietic cell transplantation-specific comorbidity index (HCT-CI) predicts survival and non-relapse mortality in lymphoma and myeloma patients receiving a RIC allograft 105
Allogeneic transplantation for lymphoma : long-term outcome 103
Hematopoietic stem cell transplantation in peripheral T-cell lymphomas 100
Serum thymus and activation-regulated chemokine level monitoring may predict disease relapse detected by pet scan after reduced-intensity allogeneic stem cell transplantation in patients with Hodgkin lymphoma 100
Qualitative and Quantitative PCR Monitoring of MRD: Practical Implications of a Surrogate Marker for GVL Effect after RIC Allogeneic Transplantation in Relapsed Chronic Lymphocytic Leukemia. 98
Phase II study of perifosine and sorafenib dual-targeted therapy in patients with relapsed or refractory lymphoproliferative diseases 96
Current state of art for transplantation paradigms in peripheral T-cell lymphomas 94
Long-term molecular remission with lenalidomide treatment of relapsed chronic lymphocytic leukemia 87
Molecular methods used for the detection of autologous graft contamination in lymphoid disorders 82
A rare case of atypical chronic lymphocytic leukaemia presenting as nephrotic syndrome 82
Predicting failure of hematopoietic stem cell mobilization before it starts : the predicted poor mobilizer (pPM) score 56
Prospective Validation of CAR-HEMATOTOX and a simplified version predict Survival in Patients with Large B-Cell Lymphoma treated with anti-CD19 CAR T-cells: data from CART-SIE study 1
Totale 5.488
Categoria #
all - tutte 14.456
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 14.456


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020226 0 0 0 0 0 0 0 0 124 64 23 15
2020/2021796 63 74 60 10 53 68 29 20 80 90 202 47
2021/2022520 76 17 51 25 45 31 61 20 38 33 21 102
2022/2023653 82 70 75 63 79 136 2 21 55 9 47 14
2023/2024547 6 24 11 21 96 38 59 56 21 51 73 91
2024/2025626 64 131 48 110 80 20 18 93 62 0 0 0
Totale 5.488